Immunic, Inc. is trading at $13.65 (down 5.4%) following a sharp sell-off in growth and risk assets triggered by a stronger-than-expected U.S. jobs report.
- The robust employment data has reduced market expectations for near-term Federal Reserve rate cuts, placing significant pressure on high-beta names and the broader Nasdaq.
- No company-specific clinical, regulatory, or corporate announcements have been released today, suggesting the downward move is driven by macroeconomic factors.